TreeFrog .. great post
when I finally had a chance to see the email from IPI yesterday morning
noticed the first line the second paragraph had the word highlighted
I then immediately went to the company's website to see if that was the same
and it was ..
http://www.ipharminc.com/press-release/2019/9...-the-colon
clicking on the word OralogiK™ brings one to this link from May 2018
Novartis licenses BDD Pharma’s timed-release oral drug-delivery tech
MAY 30, 2018 BY SARAH FAULKNER
BDD PharmaPrivately-held BDD Pharma said today that it signed a deal to license its OralogiK timed drug-delivery tech to Novartis (NYSE:NVS).
Financial details of the agreement were not disclosed, but BDD noted that it included an upfront payment, milestones and future royalties.
BDD’s technology can deliver multiple doses or a combination of drugs at pre-determined times, between one and 12 hours following administration, according to the company.
Novartis plans to use OralogiK to develop a new product but did not say what kind of drug would be included in the oral drug-delivery system.
“This is a significant step for BDD; our OralogiK technology offers wide ranging possibilities for partners to develop new products with complex delivery patterns and to extend product ranges. We look forward to continuing our collaboration with Novartis, aiming to bring the first OralogiK product to the market,” BDD’s executive chairman Howard Stevens said in prepared remarks
https://www.drugdeliverybusiness.com/novartis...very-tech/
imo key line in the above:
beyond curious as to what IPI 8K's next ..
thx for the post here on IHANG ..
4kids
when I finally had a chance to see the email from IPI yesterday morning
noticed the first line the second paragraph had the word highlighted
Quote:
Brilacidin tablet design employs BDD Pharma’s patented OralogiK™ technology to provide controlled erosion of a time-dependent barrier layer during small intestine transit.
I then immediately went to the company's website to see if that was the same
and it was ..
http://www.ipharminc.com/press-release/2019/9...-the-colon
clicking on the word OralogiK™ brings one to this link from May 2018
Novartis licenses BDD Pharma’s timed-release oral drug-delivery tech
MAY 30, 2018 BY SARAH FAULKNER
BDD PharmaPrivately-held BDD Pharma said today that it signed a deal to license its OralogiK timed drug-delivery tech to Novartis (NYSE:NVS).
Financial details of the agreement were not disclosed, but BDD noted that it included an upfront payment, milestones and future royalties.
BDD’s technology can deliver multiple doses or a combination of drugs at pre-determined times, between one and 12 hours following administration, according to the company.
Novartis plans to use OralogiK to develop a new product but did not say what kind of drug would be included in the oral drug-delivery system.
“This is a significant step for BDD; our OralogiK technology offers wide ranging possibilities for partners to develop new products with complex delivery patterns and to extend product ranges. We look forward to continuing our collaboration with Novartis, aiming to bring the first OralogiK product to the market,” BDD’s executive chairman Howard Stevens said in prepared remarks
https://www.drugdeliverybusiness.com/novartis...very-tech/
imo key line in the above:
Quote:
Novartis plans to use OralogiK to develop a new product but did not say what kind of drug would be included in the oral drug-delivery system.
beyond curious as to what IPI 8K's next ..
thx for the post here on IHANG ..
4kids
Quote:
As pointed out elsewhere, did anyone here notice that the PR from yesterday had a link for OralogiK that went to the Novartis BDD deal from May of 2018? Is that an error? Shouldn't it have gone directly to the BDD site. Check it out.
https://www.otcmarkets.com/stock/IPIX/news/In...?id=240470
3
